Four things to know:
- The government will not recommend one drugmaker’s booster over another, federal officials told The New York Times. The U.S. will likely say that while it’s preferable to use a booster made by the same drugmaker that produced a person’s original vaccine, providers can use their discretion to offer boosters made by a different drugmaker.
- A National Institutes of Health study on mixing COVID-19 vaccine doses showed that people who were vaccinated with Johnson & Johnson’s COVID-19 shot would receive greater protection if they got a booster made by Moderna or Pfizer. It was published Oct. 13 in preprint server MedRxiv.
- The FDA is expected to approve Moderna and Johnson & Johnson boosters this week, greatly expanding the number of Americans eligible for COVID-19 boosters.
- State officials have been pushing for the option to mix and match COVID-19 boosters for weeks. Many say the option allows for a more streamlined booster rollout, as states often have a greater supply of one vaccine over the others.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
